TB-500 vs LL-37

TB-500 is a synthetic peptide corresponding to the active region of thymosin beta-4, a 43-amino-acid protein involved in actin polymerization, cell migration, and differentiation. Preclinical research has demonstrated its role in modulating inflammatory responses and promoting tissue repair through upregulation of actin-binding proteins. TB-500 is widely studied in connective tissue, cardiovascular, and wound-healing models as a key regulator of cytoskeletal dynamics. LL-37 is the sole human cathelicidin antimicrobial peptide, a 37-amino-acid fragment cleaved from the hCAP-18 precursor protein. Beyond its well-characterized antimicrobial activity against bacteria, fungi, and enveloped viruses, LL-37 has emerged as a significant immunomodulatory molecule in preclinical research. Studies have documented its effects on wound closure, angiogenesis promotion, and modulation of NF-kB-mediated inflammatory cascades.

TB-500

Origin Thymosin beta-4 fragment (thymus-derived)
Primary Mechanism Actin regulation, cell migration
Research Focus Connective tissue repair, inflammation
Key Pathways Actin polymerization, VEGF signaling
Molecular Weight ~4,921 Da (active fragment)
Study Model Context Cardiovascular, musculoskeletal, dermal
Administration Frequency Typically 2x per week in protocols

LL-37

Origin Cathelicidin (hCAP-18 cleavage product)
Primary Mechanism Antimicrobial activity, immune modulation
Research Focus Microbial defense, wound closure, immune signaling
Key Pathways NF-kB modulation, TLR signaling, angiogenesis
Molecular Weight ~4,493 Da
Study Model Context Dermal, mucosal, gastrointestinal
Administration Frequency Variable; model-dependent

The Verdict

TB-500 and LL-37 both appear in inflammation and repair research but through markedly different mechanisms. TB-500 operates primarily through cytoskeletal regulation, promoting cell migration and tissue organization via actin dynamics. LL-37 functions as both a direct antimicrobial agent and an immunomodulatory signal, influencing innate immune pathways and wound-healing cascades. In study models where microbial challenge is a variable, LL-37 offers a dual-function advantage. For purely structural repair contexts without an infectious component, TB-500 is more directly relevant. Researchers studying complex wound environments where both structural repair and immune defense are factors may find value in examining both compounds.

Explore These Products

TB-500

A synthetic fragment of thymosin beta-4 studied for its role in tissue repair, cell migration, and anti-inflammatory activity in research.

View Details →

LL-37

A 37-amino acid antimicrobial peptide and the only human cathelicidin, studied for broad-spectrum antimicrobial activity, immune modulation, and wound healing.

View Details →

TB-500 vs LL-37 — FAQ

Is LL-37 only an antimicrobial peptide?
No. While LL-37 was initially characterized for its broad-spectrum antimicrobial activity, subsequent research has revealed significant immunomodulatory and pro-repair functions including angiogenesis promotion, wound closure acceleration, and NF-kB pathway modulation in preclinical models.
How does TB-500 promote tissue repair?
TB-500 upregulates actin-binding proteins that facilitate cell migration and cytoskeletal reorganization. This promotes the movement of repair cells into damaged areas. It also modulates inflammatory mediators and has been shown to influence VEGF-mediated angiogenesis in preclinical study models.
Can TB-500 and LL-37 be studied in the same protocol?
Yes. Their mechanisms are distinct and non-overlapping. TB-500 addresses structural repair via actin dynamics while LL-37 addresses immune modulation and antimicrobial defense. Combined protocols may be relevant in study models involving both tissue damage and microbial challenge.
What is the regulatory status of TB-500 and LL-37?
Both TB-500 and LL-37 are sold as research-use-only compounds intended for in-vitro and preclinical study models. Neither is approved for human use.

References

Primary sources for key clinical and regulatory claims on this page.

  1. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues — PubMed / Trends Mol Med . Primary source describing thymosin beta-4 repair biology and actin-sequestering mechanisms underpinning TB-500 research.
  2. LL-37, the only human member of the cathelicidin family of antimicrobial peptides — PubMed / Biochim Biophys Acta . Foundational review of LL-37 antimicrobial and immunomodulatory functions in innate immunity.

Keep Researching

Use the surrounding category and guide pages to move from a side-by-side comparison into the broader decision path.

Research Peptides CategoryRecovery Hub
Updated March 2026. This comparison is reviewed for catalog accuracy, sourcing language, and consistency with our public quality standards. It is an educational summary for research reference only. Read our Editorial Standards.

Ready to order?

Pick your product and check out in under 3 minutes.

Shop Now